LEO PHARMA - TACROLIMUS
LEO PHARMA - TACROLIMUS
Approved
DIN Number
02531380
Drug Class
Human
Market Date
N/A
Company
HC
leo pharma gen, a division of leo pharma inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02531380
AIG Number0127857004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
D11AH01 TACROLIMUS
Product Specifications
Dosage FormOintment
Route of AdministrationTopical
AHFS Classification84:06.28
Health Canada Classification
ACTIVE INGREDIENTS (1)
TACROLIMUSActive
Strength: 0.1 % / W/W
Monograph: TACROLIMUS